Cognex (CGNX) PT Raised to $35 at DA Davidson

DA Davidson analyst Matthew Summerville raised the price target on Cognex (NASDAQ: CGNX) to $35.00 (from $32.00) while maintaining a Neutral rating.

The analyst commented, "We increased our sales and EPS projections for CGNX for both 2025 and 2026, as this downcycle in demand may have bottomed, although it is a bit tough to gauge whether CGNX is poised for sustained inflection from here based on ongoing end market cross currents. That said, upside seen in 2Q25 and its current guide for 3Q25 were encouraging, particularly with respect to emphasis on expense optimization and free cash flow Logistics, Packaging and CE are performing well, offset by weakness in Semicon and Auto and unfavorable mix. NEUTRAL maintained, PT to $35."

You May Also Be Interested In

• Marvell (MRVL) PT Raised to $325 at Oppenheimer
• Affirm Holdings (AFRM) PT Raised to $101 at BMO Capital
• Elastic NV. (ESTC) PT Raised to $107 at Stifel as Sales Revenue Accelerates